Literature DB >> 19570772

Prevalence of pterygium in Latinos: Proyecto VER.

S West1, B Muñoz.   

Abstract

AIMS: Pterygium is a common corneal eye condition that can be disfiguring and may require surgery to avoid loss of vision. There are no population-based data on the prevalence or on risk factors among Latinos.
METHODS: A population-based sample of 4774 self-reported Latinos age > or = 40 years from randomly selected block groups in Nogales and Tucson, Arizona, USA, were enrolled in the study. Questionnaires were conducted in the home on risk factors. A clinical examination by an experienced ophthalmologist was carried out, and the presence of pterygium was diagnosed at the examination.
RESULTS: The prevalence of pterygium was high (overall 16%). Men had a higher rate than women (23.7% versus 11.5%, respectively). Low income and low educational status were associated with higher odds of pterygium. Current smoking, and smoking dose, was protective for pterygium; this finding has now been reported from several studies.
CONCLUSIONS: Pterygium rates were high in this population of Latinos. Socioeconomic status markers for increased exposure to sunlight suggest this may be the target of simple interventions to reduce the risk of pterygium in this ethnic population.

Entities:  

Mesh:

Year:  2009        PMID: 19570772     DOI: 10.1136/bjo.2008.152694

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  28 in total

1.  Prevalence of pinguecula and pterygium in a general population in Spain.

Authors:  E Viso; F Gude; M T Rodríguez-Ares
Journal:  Eye (Lond)       Date:  2010-12-24       Impact factor: 3.775

2.  Distribution of conjunctival ultraviolet autofluorescence in a population-based study: the Norfolk Island Eye Study.

Authors:  J C Sherwin; A W Hewitt; L S Kearns; M T Coroneo; L R Griffiths; D A Mackey
Journal:  Eye (Lond)       Date:  2011-04-15       Impact factor: 3.775

3.  Associated morbidity of nasolacrimal duct obstruction--a large community based case-control study.

Authors:  Arie Y Nemet; Shlomo Vinker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-22       Impact factor: 3.117

4.  Prevalence and racial differences in pterygium: a cross-sectional study in Han and Uygur adults in Xinjiang, China.

Authors:  Ting Chen; Lin Ding; Guangliang Shan; Limujiang Ke; Jin Ma; Yong Zhong
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-01-27       Impact factor: 4.799

5.  Effectiveness of amniotic membrane transplantation combined with mitomycin C in the treatment of pterygium: a meta-analysis.

Authors:  Yin-Wei Song; Ai-Hua Yu; Xiao-Jun Cai
Journal:  Int J Ophthalmol       Date:  2010-12-18       Impact factor: 1.779

6.  Risk Factors for Pterygium in Ilam Province, Iran.

Authors:  Parviz Malekifar; Hamed Esfandiari; Nazanin Behnaz; Fatemeh Javadi; Sima Azish; Mohammad Ali Javadi; Masumeh Kalantarion
Journal:  J Ophthalmic Vis Res       Date:  2017 Jul-Sep

7.  Prevalence and associated factors for pterygium in a Chinese rural population with type 2 diabetes in a cross-sectional study: Jiangsu Diabetic Eye Disease Study (JDEDS).

Authors:  Junfang Zhang; Bai Qin; Bihong Liu; Dajun Sun; Congkai Liang; Shiyi Wang; Mei Yang; Rongrong Zhu
Journal:  Int Ophthalmol       Date:  2022-08-10       Impact factor: 2.029

Review 8.  Pterygium: an update on pathophysiology, clinical features, and management.

Authors:  Toktam Shahraki; Amir Arabi; Sepehr Feizi
Journal:  Ther Adv Ophthalmol       Date:  2021-05-31

9.  Preoperative factors influencing success in pterygium surgery.

Authors:  Ana Torres-Gimeno; Lucía Martínez-Costa; Guillermo Ayala
Journal:  BMC Ophthalmol       Date:  2012-08-08       Impact factor: 2.209

10.  Prevalence of pterygium in a population in Northern Japan: the Locomotive Syndrome and Health Outcome in Aizu Cohort Study.

Authors:  Takatoshi Tano; Koichi Ono; Yoshimune Hiratsuka; Koji Otani; Miho Sekiguchi; Shinichi Konno; Shinichi Kikuchi; Yoshihiro Onishi; Misa Takegami; Masakazu Yamada; Shunichi Fukuhara; Akira Murakami
Journal:  Acta Ophthalmol       Date:  2013-04-01       Impact factor: 3.761

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.